In particular,

the introduction of a selective adolescent varicella vaccination programme may be cost-effective Selleckchem KU 55933 [5]. Given that most adolescents will have acquired natural immunity, the cost-effectiveness of this approach will largely depend upon accurate pre-immunisation identification of susceptibles to minimise vaccine wastage in those already immune. Two screening methods are available: reported chickenpox history, or laboratory testing for VZV-specific immunoglobulin G (IgG) antibody, which is significantly more expensive, more time consuming and likely to involve higher dropout rates. Understanding the validity of reported chickenpox history in the IDH inhibitor target group is essential to inform this decision, and to model the impact and cost-effectiveness of the overall

approach. Oral fluid (gingivocrevicular fluid) is simple and non-invasive to collect, and with appropriately sensitive assays can be used for the detection of viral antibodies for seroprevlance studies [8]. This study estimates the proportions of adolescents already immune to VZV, by reported chickenpox history, using detection of VZV-specific antibodies in oral fluid as a serological correlate suggesting previous infection. Recruitment occurred during February to September 2012. The study aimed to recruit a group broadly representative of the British general population, where approximately

15% of adolescents are of non-white ethnicity, [9] because differences in the predictive value of chickenpox history by ethnicity have been reported. [10] and [11] Adolescents were therefore recruited through two secondary schools in South London to increase the number of non-white participants, and two other regions of England (Hertfordshire and Gloucestershire). Participating schools provided all students aged ADP ribosylation factor 11–15 with study information packs to take home to their parents. Individuals with any serious health condition causing immune dysfunction, who would be ineligible to receive a live vaccine, and those who had previously received a varicella vaccine were excluded. Study packs asked parents to return a short questionnaire by post, including their child’s ethnicity and the following question about chickenpox history: “Most children will have had chickenpox by the time they are 10 years old. Chickenpox infection provides long-term protection against future infection and there is no need for vaccination if someone has already had chickenpox. We want you to think about your child’s history of chickenpox in this context. Has your child had chickenpox?” Answers were: (1) “Yes (If yes, your child does not need chickenpox vaccine)”, (2) “No” or (3) “I don’t know”.